Aktienanalyse zu Integer Holdings Corp (ITGR)ITGRInteger Holdings Corp

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is not a good buy right now. The current price is $125.33, which is very close to the acquisition price of $127 set by KKR, limiting upside potential. Additionally, the RSI is at 75.998, indicating that the stock is overbought. While the company reported a Q2 non-GAAP EPS of $1.60, beating expectations, the withdrawal of future guidance due to the acquisition raises concerns about future performance. The main risk is the uncertainty surrounding the acquisition and potential fiduciary breaches, as highlighted by recent investigations.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.